DaVita Inc. (DVA): Price and Financial Metrics

DaVita Inc. (DVA): $74.34

1.11 (+1.52%)

POWR Rating

Component Grades














  • DVA scores best on the Value dimension, with a Value rank ahead of 90.4% of US stocks.
  • The strongest trend for DVA is in Momentum, which has been heading up over the past 179 days.
  • DVA ranks lowest in Sentiment; there it ranks in the 11th percentile.

DVA Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for DVA is 21.85 -- better than 98.76% of US stocks.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 24.95 for DAVITA INC; that's greater than it is for 98.43% of US stocks.
  • DAVITA INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 21.53%, greater than the shareholder yield of 92.85% of stocks in our set.
  • Stocks with similar financial metrics, market capitalization, and price volatility to DAVITA INC are CNK, IRM, RRGB, BLMN, and GMBL.
  • DVA's SEC filings can be seen here. And to visit DAVITA INC's official web site, go to www.davita.com.

DVA Valuation Summary

  • DVA's price/sales ratio is 0.5; this is 73.68% lower than that of the median Healthcare stock.
  • DVA's price/sales ratio has moved down 0.4 over the prior 243 months.

Below are key valuation metrics over time for DVA.

Stock Date P/S P/B P/E EV/EBIT
DVA 2022-11-01 0.5 11.8 9.3 14.4
DVA 2022-10-31 0.6 12.3 9.7 14.7
DVA 2022-10-28 0.6 10.6 7.7 13.1
DVA 2022-10-27 0.8 14.6 10.6 14.9
DVA 2022-10-26 0.8 15.0 10.9 15.0
DVA 2022-10-25 0.7 14.4 10.4 14.8

DVA Growth Metrics

    The year over year price growth rate now stands at -6.58%.
  • Its year over year cash and equivalents growth rate is now at -60.36%.
  • Its year over year net cashflow from operations growth rate is now at 18.38%.
Over the past 15 months, DVA's revenue has gone up $71,074,000.

The table below shows DVA's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 11,636.97 1,750.736 679.77
2022-06-30 11,626.6 1,607.156 834.158
2022-03-31 11,616.35 2,098.767 903.169
2021-12-31 11,618.8 1,930.876 978.45
2021-09-30 11,580.15 1,885.786 964.75
2021-06-30 11,565.9 1,801.561 863.67

DVA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • DVA has a Quality Grade of B, ranking ahead of 81.19% of graded US stocks.
  • DVA's asset turnover comes in at 0.661 -- ranking 45th of 81 Healthcare stocks.
  • LHCG, NTRA, and CHE are the stocks whose asset turnover ratios are most correlated with DVA.

The table below shows DVA's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-09-30 0.661 0.312 0.082
2021-06-30 0.666 0.314 0.078
2021-03-31 0.650 0.310 0.074
2020-12-31 0.651 0.308 0.077
2020-09-30 0.648 0.313 0.083
2020-06-30 0.643 0.310 0.082

DVA Price Target

For more insight on analysts targets of DVA, see our DVA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $143.11 Average Broker Recommendation 2 (Hold)

DVA Stock Price Chart Interactive Chart >

Price chart for DVA

DVA Price/Volume Stats

Current price $74.34 52-week high $124.81
Prev. close $73.23 52-week low $65.28
Day low $72.81 Volume 463,200
Day high $74.65 Avg. volume 813,754
50-day MA $79.93 Dividend yield N/A
200-day MA $93.77 Market Cap 6.70B

DaVita Inc. (DVA) Company Bio

DaVita Inc. provides kidney dialysis services through a network of 2,816 outpatient dialysis centers in the United States, serving 204,200 patients, and 321 outpatient dialysis centers in 10 other countries serving 3,200 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo dialysis 3 times per week for the rest of their lives unless they receive a donor kidney. The company has a 37% market share in the U.S. dialysis market. It is organized in Delaware and based in Denver. (Source:Wikipedia)

DVA Latest News Stream

Event/Time News Detail
Loading, please wait...

DVA Latest Social Stream

Loading social stream, please wait...

View Full DVA Social Stream

Latest DVA News From Around the Web

Below are the latest news stories about DAVITA INC that investors may wish to consider to help them evaluate DVA as an investment opportunity.

Are Options Traders Betting on a Big Move in DaVita (DVA) Stock?

Investors need to pay close attention to DaVita (DVA) stock based on the movements in the options market lately.

Yahoo | November 11, 2022

John Nehra Is The Independent Director of DaVita Inc. (NYSE:DVA) And They Just Picked Up 7.3% More Shares

Potential DaVita Inc. ( NYSE:DVA ) shareholders may wish to note that the Independent Director, John Nehra, recently...

Yahoo | November 10, 2022

DaVita Inc. – Consensus Indicates Potential 18.8% Upside

DaVita Inc. with ticker code (DVA) have now 8 analysts in total covering the stock. The consensus rating is ''Hold''. The range between the high target price and low target price is between 109 and 72 calculating the average target price we see 83.63. Now with the previous closing price of 70.38 this now indicates there is a potential upside of 18.8%. There is a 50 day moving average of 87.18 and the 200 day moving average is 97.59. The company has a market capitalisation of $6,395m. Visit the company website at: https://www.davita.com [stock_market_widget type="chart" template="basic" color="green" assets="DVA" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $7,599m based on the market concensus. DaVita Inc. provides kidney dialysis servi...

DirectorsTalk | November 8, 2022

15 Best Warren Buffett Stocks to Buy Now

In this article, we discuss the 15 best stock picks of Warren Buffett. If you want to skip our detailed analysis of these stocks, go directly to the 5 Best Warren Buffett Stocks To Buy Now. Warren Buffett’s investment strategy is an open secret now: invest in solid companies and hold their stocks forever. But […]

Yahoo | November 8, 2022

Bearish Bets: 3 Brand-Name Stocks You Should Consider Shorting This Week

Tesla Inc. (TSLA), Advanced Micro Devices (AMD) and DaVita Inc. (DVA) are three bearish-looking stocks that you should consider shorting this week, writes technical analyst Bob Lang in his latest edition of Bearish Bets….TSLA

The Street RealMoney | November 6, 2022

Read More 'DVA' Stories Here

DVA Price Returns

1-mo 8.46%
3-mo -15.33%
6-mo -22.42%
1-year -24.79%
3-year 2.45%
5-year 20.04%
YTD -34.65%
2021 -3.10%
2020 56.47%
2019 45.80%
2018 -28.78%
2017 12.54%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.8145 seconds.